Published in Br J Cancer on November 01, 1987
Animal model of human disease. Multiple myeloma. Am J Pathol (1988) 2.08
A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse. Br J Cancer (1992) 1.03
Immunological dysregulation in multiple myeloma microenvironment. Biomed Res Int (2014) 0.98
Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma-induced bone disease in a novel murine plasmacytoma xenograft model. Blood (2010) 0.85
Animal Models of Bone Metastasis. Vet Pathol (2015) 0.84
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4. BMC Cancer (2011) 0.83
An in vivo model of human multidrug-resistant multiple myeloma in SCID mice. Am J Pathol (1993) 0.79
The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations. Br J Cancer (1990) 0.78
An immunofluorescence procedure for the detection of intracellular immunoglobulins. Clin Exp Immunol (1969) 4.77
A rapid single step staining technique for DNA analysis by flow microfluorimetry. J Histochem Cytochem (1980) 2.76
Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol (1979) 2.60
Cellular DNA content as a marker of human multiple myeloma. Blood (1980) 1.83
Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer (1985) 1.74
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest (1985) 1.30
Occurrence and potential significance of increased numbers of T cells with Fc receptors in myeloma. Immunol Rev (1981) 1.11
Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation. J Immunol (1977) 1.03
In vitro immunoglobulin production by peripheral blood mononuclear cells from multiple myeloma patients and patients with benign monoclonal gammopathy. Regulation by cell subsets. Scand J Immunol (1984) 1.00
Light scattering properties of murine hemopoietic cells. Blood Cells (1980) 0.96
Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications. Adv Cancer Res (1984) 0.95
Age-related changes in the relative numbers of Thy-1- and Lyt-2-bearing peripheral blood lymphocytes in mice: a longitudinal approach. Cell Immunol (1985) 0.86
Cytogenetic evidence that the malignant event in multiple myeloma occurs in a precursor lymphocyte. Cancer Genet Cytogenet (1985) 0.83
Intratumor maturational heterogeneity within the murine myeloma MOPC-315. Cancer Res (1981) 0.82
Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol (1979) 2.60
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A (1996) 2.38
Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol (1986) 2.20
Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine (2000) 1.90
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int (1997) 1.88
DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nat Med (1998) 1.83
Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J Clin Microbiol (1985) 1.80
Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet (1984) 1.79
Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues. J Immunol (1984) 1.78
Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer (1985) 1.74
A murine model of human myeloma bone disease. Bone (1997) 1.53
Idiopathic paraproteinaemia. I. Studies in an animal model--the ageing C57BL/KaLwRij mouse. Clin Exp Immunol (1978) 1.48
Immunoglobulin patterns in humans over 95 years of age. Clin Exp Immunol (1975) 1.41
Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease. Blood (1999) 1.40
Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. J Med Virol (1998) 1.34
The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J Biotechnol (1996) 1.34
Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J Immunol Methods (1986) 1.32
Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int (1984) 1.32
Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer (1997) 1.30
In vivo kinetics and characterization of IFN-gamma-producing cells during a thymus-independent immune response. J Immunol (1991) 1.27
Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of the 2nd IUIS/WHO collaborative study. Immunol Lett (1992) 1.26
Animal model of human disease. Benign monoclonal gammopathy (idiopathic paraproteinemia). Am J Pathol (1981) 1.25
The 5TMM series: a useful in vivo mouse model of human multiple myeloma. Hematol J (2000) 1.25
Instability of the human immunoglobulin heavy chain constant region locus indicated by different inherited chromosomal deletions. Mol Biol Med (1983) 1.23
Complement-mediated follicular localization of T-independent type-2 antigens: the role of marginal zone macrophages revisited. Eur J Immunol (1992) 1.20
Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol (1992) 1.18
Idiopathic paraproteinemia--a consequence of an age-related deficiency in the T immune system. Three-stage development--a hypothesis. Clin Immunol Immunopathol (1979) 1.13
The origin of monomeric and polymeric forms of IgA in man. Adv Exp Med Biol (1974) 1.11
Immunoglobulins and transient paraproteins in sera of patients with the Wiskott-Aldrich syndrome: a follow-up study. Clin Exp Immunol (1976) 1.06
Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol (1991) 1.05
Idiopathic paraproteinemia. III. Increased frequency of paraproteinemia in thymectomized aging C57BL/KaLwRij and CBA/BrARij mice. J Immunol (1980) 1.04
The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol (1988) 1.04
Immunological functions and in vivo cell-cell interactions of T cells in the spleen. Crit Rev Immunol (1992) 1.03
Long-term effects of social stress on antiviral immunity in pigs. Physiol Behav (2001) 1.03
Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunol Lett (1992) 1.03
Increased frequency of homogeneous immunoglobulins in the sera of nude athymic mice with age. Clin Immunol Immunopathol (1980) 1.02
Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine (2001) 1.02
Follow-up of bone lesions in an experimental multiple myeloma mouse model: description of an in vivo technique using radiography dedicated for mammography. Br J Cancer (1996) 0.99
Detection of human cytokines in situ using antibody and probe based methods. J Immunol Methods (1995) 0.99
The nature of the polymeric serum IgA in man. Proc Soc Exp Biol Med (1975) 0.99
IgD idiopathic paraproteinemia in the aging C57BL/KaLwRij mouse. J Immunol (1980) 0.99
The cellular basis of double paraproteinemia in man. Clin Immunol Immunopathol (1978) 0.98
Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation. Clin Immunol Immunopathol (1985) 0.98
Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response. Vet Q (1998) 0.97
Serum immunoglobulins in nude mice and their heterozygous littermates during ageing. Immunology (1980) 0.97
Autoantibodies in highly aged humans. Mech Ageing Dev (1984) 0.97
Monoclonal gammopathies in human aging: increased occurrence with age and correlation with health status. Mech Ageing Dev (1990) 0.97
Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. Kidney Int (1989) 0.97
Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative study. J Immunol Methods (1996) 0.96
Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. Blood (1994) 0.96
Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica cathepsin L-like protease. Int J Parasitol (2001) 0.96
Monoclonal gammapathies. An attempt at a new classification. Neth J Med (1985) 0.95
Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood (1993) 0.95
A rapid, simple, and reliable technique for preparation of antisera against idiotypes of homogeneous immunoglobulins. Vox Sang (1978) 0.94
Oral administration of TNP-Lactobacillus conjugates in mice: a model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli. Res Microbiol (1991) 0.93
Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry. J Pathol (1990) 0.93
Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pre-treatment. J Histochem Cytochem (1994) 0.93
Monoclonal gammopathies in children. J Clin Immunol (1989) 0.93
A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody. AIDS Res Hum Retroviruses (1993) 0.92
Immunohistochemical detection of co-localizing cytokine and antibody producing cells in the extrafollicular area of human palatine tonsils. Clin Exp Immunol (1993) 0.92
Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens. Vet Immunol Immunopathol (2001) 0.91
Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin Exp Immunol (1994) 0.91
The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood (1996) 0.91
Site of catabolism of autologous and heterologous IgA in non-human primates. Scand J Immunol (1990) 0.90
Idiopathic paraproteinaemia. IV. The role of genetic factors in the development of monoclonal B cell proliferative disorders--a study in the ageing C57BL/KaLwRij and CBA/BrARij mouse radiation chimeras. Clin Exp Immunol (1984) 0.90
The regulatory influence of the thymus-dependent immune system on the heterogeneity of immunoglobulins in irradiated and reconstituted mice. Adv Exp Med Biol (1976) 0.90
Homogeneous immunoglobulins in the serum of irradiated and bone marrow reconstituted mice: the role of thymus and spleen. Immunology (1979) 0.90
Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp Immunol (1988) 0.89
Switch recombination in normal IgA1+ B lymphocytes. Proc Natl Acad Sci U S A (1994) 0.89
Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine. Vaccine (1996) 0.87
IgG subclass distribution in juvenile human tonsil: IgG3 and IgG4 results of specific antibody production using synthetic peptides. Adv Exp Med Biol (1988) 0.87
Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor. Biochem J (1993) 0.87
Marginal zone of the murine spleen in autotransplants: functional and histological observations in the response against a thymus-independent type 2 antigen. Clin Exp Immunol (1989) 0.86
Age-related changes in the relative numbers of Thy-1- and Lyt-2-bearing peripheral blood lymphocytes in mice: a longitudinal approach. Cell Immunol (1985) 0.86
Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumours with clinical features of human disease. Immunology (1998) 0.86
Developmental pattern and regulation by androgens of androgen receptor expression in the urogenital tract of the rat. Mol Cell Endocrinol (1995) 0.86
Cellular origins of human polymeric and monomeric IgA: enumeration of single cells secreting polymeric IgA1 and IgA2 in peripheral blood, bone marrow, spleen, gingiva and synovial tissue. Clin Exp Immunol (1991) 0.85
Post-irradiation thymocyte regeneration after bone marrow transplantation. II. Physical characteristics of thymocyte progenitor cells. Cell Tissue Kinet (1981) 0.85
In vivo T-B cell interactions and cytokine-production in the spleen. Semin Immunol (1994) 0.85
Immune regulation of mouse 5T2 multiple myeloma. I. Immune response to 5T2 MM idiotype. Neoplasma (1991) 0.85
Vectorial transcytosis of dimeric IgA by the Calu-3 human lung epithelial cell line: upregulation by IFN-gamma. Am J Physiol (1997) 0.85
Occurrence of IgA subclasses (IgA1 and IgA2) in the human nervous system. Correlation with disease. Int Arch Allergy Appl Immunol (1985) 0.85
Idiopathic paraproteinaemia V. Expression of Igh1 and Igh5 allotypes within the homogeneous immunoglobulins of ageing (C57BL/LiARij X CBA/BrARij)F1 mouse. Clin Exp Immunol (1985) 0.85
Synthetic peptide conjugates with horseradish peroxidase and beta-galactosidase for use in epitope-specific immunocytochemistry and ELISA. J Immunol Methods (1991) 0.84
Cytogenetic findings in mouse multiple myeloma and Waldenström's macroglobulinemia. Cancer Genet Cytogenet (1996) 0.84
Immune regulation of 5T2 mouse multiple myeloma. II. Immunological treatment of 5T2 MM residual disease. Neoplasma (1991) 0.83
Characterization of polyclonal antibodies against the N-terminal domain of the human androgen receptor. Mol Cell Endocrinol (1989) 0.83
Peptide-induced memory (IgG) response, cross-reactive with native proteins, requires covalent linkage of a specific B cell epitope with a T cell epitope. Eur J Immunol (1993) 0.83
Gastrointestinal AAPOAII and systemic AA-amyloidosis in aged C57BL/Ka mice. Amyloid-type dependent effect of long-term immunosuppressive treatment. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 0.82
Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccines. Adv Exp Med Biol (1987) 0.82
Double immunocytochemical staining for in vivo detection of epitope specificity and isotype of antibody-forming cells against synthetic peptides homologous to human immunodeficiency virus-1. J Histochem Cytochem (1990) 0.82
Serum immunoglobulin class and IgG subclass levels and the occurrence of homogeneous immunoglobulins during the course of ageing in humans. Mech Ageing Dev (1992) 0.82
Immunocytochemical determination of antigen and epitope specificity of HIV-1-specific B cells in lymph-node biopsies from HIV-1-infected individuals. AIDS (1991) 0.82
Differences among the three major categories of paraproteinaemias in aging man and the mouse. A minireview. Mech Ageing Dev (1984) 0.81